CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • United States
    Entity • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Trade Better Therapeutics, Inc. - BTTX CFD

    0.6830
    2.2%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.0562
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		-0.025457%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		0.003235%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 20%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 0.6683
    Open* 0.6671
    1-Year Change* -67.3%
    Day's Range* 0.6486 - 0.7027
    52 wk Range 0.59-2.80
    Average Volume (10 days) 135.87K
    Average Volume (3 months) 2.90M
    Market Cap 21.89M
    P/E Ratio -100.00K
    Shares Outstanding 31.73M
    Revenue N/A
    EPS -1.67
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date Aug 9, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    May 26, 2023 0.6830 0.0159 2.38% 0.6671 0.7263 0.6480
    May 25, 2023 0.6683 -0.0257 -3.70% 0.6940 0.7422 0.6483
    May 24, 2023 0.7168 -0.0290 -3.89% 0.7458 0.7459 0.6924
    May 23, 2023 0.7507 0.0054 0.72% 0.7453 0.7651 0.7453
    May 22, 2023 0.7555 0.0201 2.73% 0.7354 0.7942 0.7354
    May 19, 2023 0.7564 0.0013 0.17% 0.7551 0.7747 0.7540
    May 18, 2023 0.7554 -0.0015 -0.20% 0.7569 0.7845 0.7356
    May 17, 2023 0.7582 0.0126 1.69% 0.7456 0.7797 0.7456
    May 16, 2023 0.7620 -0.0388 -4.85% 0.8008 0.8037 0.7260
    May 15, 2023 0.7457 -0.0580 -7.22% 0.8037 0.8136 0.7359
    May 12, 2023 0.7470 0.0310 4.33% 0.7160 0.7749 0.7159
    May 11, 2023 0.7555 -0.0823 -9.82% 0.8378 0.8571 0.7257
    May 10, 2023 0.8349 0.0215 2.64% 0.8134 0.8716 0.7544
    May 9, 2023 0.8039 0.0391 5.11% 0.7648 0.8137 0.7262
    May 8, 2023 0.7746 -0.1165 -13.07% 0.8911 0.8911 0.6907
    May 5, 2023 0.9005 0.0042 0.47% 0.8963 0.9298 0.8905
    May 4, 2023 0.9297 -0.1353 -12.70% 1.0650 1.0653 0.8708
    May 3, 2023 1.0750 0.0017 0.16% 1.0733 1.1041 1.0635
    May 2, 2023 1.0944 0.0095 0.88% 1.0849 1.1233 1.0652
    May 1, 2023 1.0943 -0.0281 -2.50% 1.1224 1.1332 1.0741

    Better Therapeutics, Inc. Events

    Time (UTC) Country Event
    Wednesday, August 9, 2023

    Time (UTC)

    20:00

    Country

    US

    Event

    Q2 2023 Better Therapeutics Inc Earnings Release
    Q2 2023 Better Therapeutics Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 13, 2023

    Time (UTC)

    21:00

    Country

    US

    Event

    Q3 2023 Better Therapeutics Inc Earnings Release
    Q3 2023 Better Therapeutics Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020
    Total revenue 0 0 0
    Total Operating Expense 38.262 40.303 0.00169
    Other Operating Expenses, Total 0.00169
    Operating Income -38.262 -40.303 -0.00169
    Net Income Before Taxes -39.753 -40.488 -0.00169
    Net Income After Taxes -39.76 -40.335 -0.00169
    Net Income Before Extra. Items -39.76 -40.335 -0.00169
    Net Income -39.76 -40.335 -0.00169
    Income Available to Common Excl. Extra. Items -39.76 -40.335 -0.00169
    Income Available to Common Incl. Extra. Items -39.76 -40.335 -0.00169
    Diluted Net Income -39.76 -40.335 -0.00169
    Diluted Weighted Average Shares 23.5578 23.6027 7.5575
    Diluted EPS Excluding Extraordinary Items -1.68776 -1.70891 -0.00022
    Dividends per Share - Common Stock Primary Issue 0
    Diluted Normalized EPS -1.68776 -1.4406 -0.00022
    Selling/General/Admin. Expenses, Total 21.822 11.124
    Research & Development 16.44 19.436
    Unusual Expense (Income) 0 9.743
    Interest Income (Expense), Net Non-Operating -1.491 -0.185
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total revenue 0 0 0 0 0
    Total Operating Expense 8.925 8.322 10.996 9.599 9.345
    Other Operating Expenses, Total
    Operating Income -8.925 -8.322 -10.996 -9.599 -9.345
    Interest Income (Expense), Net Non-Operating -0.431 -0.439 -0.406 -0.329 -0.317
    Net Income Before Taxes -9.356 -8.761 -11.402 -9.928 -9.662
    Net Income After Taxes -9.357 -8.765 -11.405 -9.928 -9.662
    Net Income Before Extra. Items -9.357 -8.765 -11.405 -9.928 -9.662
    Net Income -9.357 -8.765 -11.405 -9.928 -9.662
    Income Available to Common Excl. Extra. Items -9.357 -8.765 -11.405 -9.928 -9.662
    Income Available to Common Incl. Extra. Items -9.357 -8.765 -11.405 -9.928 -9.662
    Diluted Net Income -9.357 -8.765 -11.405 -9.928 -9.662
    Diluted Weighted Average Shares 23.8266 23.6315 23.6931 23.593 23.4132
    Diluted EPS Excluding Extraordinary Items -0.39271 -0.3709 -0.48136 -0.4208 -0.41267
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.39271 -0.3709 -0.48136 -0.4208 -0.41267
    Selling/General/Admin. Expenses, Total 5.536 5.273 5.519 5.358 5.672
    Research & Development 3.389 3.049 5.477 4.241 3.673
    Unusual Expense (Income) 0 0 0 0
    • Annual
    • Quarterly
    2022 2021 2020
    Total Current Assets 18.446 45.251 0.08666
    Cash and Short Term Investments 15.74 40.566 0.02476
    Cash 0.02476
    Other Current Assets, Total 0.21 0.276 0.06189
    Total Assets 22.943 50.958 0.08666
    Total Current Liabilities 13.494 4.733 0.06334
    Accrued Expenses 5.927 3.21 0.00145
    Notes Payable/Short Term Debt 0 0 0.06189
    Total Liabilities 23.842 14.238 0.06334
    Total Long Term Debt 10.348 9.505 0
    Total Equity -0.899 36.72 0.02331
    Common Stock 0.002 0.002 0.00014
    Additional Paid-In Capital 110.602 108.461 0.02486
    Retained Earnings (Accumulated Deficit) -111.503 -71.743 -0.00169
    Total Liabilities & Shareholders’ Equity 22.943 50.958 0.08666
    Total Common Shares Outstanding 23.851 23.6027 7.5575
    Cash & Equivalents 15.74 40.566
    Prepaid Expenses 2.496 4.409
    Property/Plant/Equipment, Total - Net 0.121 0.082
    Intangibles, Net 3.888 5.077
    Other Long Term Assets, Total 0.488 0.548
    Accounts Payable 3.035 1.523
    Long Term Debt 10.348 9.505
    Property/Plant/Equipment, Total - Gross 0.178
    Accumulated Depreciation, Total -0.057
    Current Port. of LT Debt/Capital Leases 4.532
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 8.442 18.446 23.49 32.137 35.179
    Cash and Short Term Investments 6.068 15.74 22.305 29.685 31.673
    Cash
    Prepaid Expenses 1.968 2.496 1.123 2.38 3.242
    Total Assets 12.808 22.943 28.221 37.103 40.291
    Long Term Investments
    Other Long Term Assets, Total 0.483 0.488 0.488 0.487 0.488
    Total Current Liabilities 13.64 13.494 9.312 6.141 3.567
    Accrued Expenses 5.588 5.927 4.928 3.27 2.528
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 22.641 23.842 20.969 19.049 12.866
    Total Long Term Debt 9.001 10.348 11.657 12.908 9.299
    Other Liabilities, Total
    Total Equity -9.833 -0.899 7.252 18.054 27.425
    Common Stock 0.002 0.002 0.002 0.002 0.002
    Additional Paid-In Capital 111.025 110.602 109.988 109.385 108.828
    Retained Earnings (Accumulated Deficit) -120.86 -111.503 -102.738 -91.333 -81.405
    Total Liabilities & Shareholders’ Equity 12.808 22.943 28.221 37.103 40.291
    Total Common Shares Outstanding 23.8523 23.851 23.7441 23.733 23.6086
    Payable/Accrued
    Cash & Equivalents 6.068 15.74 22.305 29.685 31.673
    Other Current Assets, Total 0.406 0.21 0.062 0.072 0.264
    Property/Plant/Equipment, Total - Net 0.131 0.121 0.122 0.115 0.098
    Intangibles, Net 3.752 3.888 4.121 4.364 4.526
    Accounts Payable 2.513 3.035 1.255 1.088 0.735
    Long Term Debt 9.001 10.348 11.657 12.908 9.299
    Current Port. of LT Debt/Capital Leases 5.539 4.532 3.129 1.783 0.304
    • Annual
    • Quarterly
    2022 2021 2020
    Net income/Starting Line -39.76 -40.335 -0.00169
    Cash From Operating Activities -28.93 -30.818 -0.00024
    Changes in Working Capital 6.268 -2.339 0.00145
    Cash From Financing Activities 5.284 72.332 0.025
    Financing Cash Flow Items 0 62.331 -0.06189
    Issuance (Retirement) of Stock, Net 0.284 0.001 0.025
    Issuance (Retirement) of Debt, Net 5 10 0.06189
    Net Change in Cash -24.826 40.443 0.02476
    Cash From Operating Activities 2.729 1.619
    Deferred Taxes 0 -0.152
    Non-Cash Items 1.833 10.389
    Cash Interest Paid 1.325 0.085
    Cash From Investing Activities -1.18 -1.071
    Capital Expenditures -1.18 -1.071
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -9.357 -39.76 -30.995 -19.59 -9.662
    Cash From Operating Activities -8.716 -28.93 -22.593 -15.57 -8.855
    Non-Cash Items 0.41 1.833 1.384 0.787 0.375
    Changes in Working Capital -0.524 6.268 5.01 1.919 -0.231
    Cash From Investing Activities -0.521 -1.18 -0.82 -0.457 -0.039
    Other Investing Cash Flow Items, Total
    Cash From Financing Activities -0.435 5.284 5.152 5.146 0.001
    Financing Cash Flow Items 0 0 0 0
    Issuance (Retirement) of Stock, Net 0 0.284 0.152 0.146 0.001
    Issuance (Retirement) of Debt, Net -0.435 5 5 5
    Net Change in Cash -9.672 -24.826 -18.261 -10.881 -8.893
    Cash From Operating Activities 0.755 2.729 2.008 1.314 0.663
    Deferred Taxes 0 0 0 0
    Cash Interest Paid 0.495 1.325 0.87 0.462 0.219
    Capital Expenditures -0.521 -1.18 -0.82 -0.457 -0.039
    Cash Taxes Paid 0
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Perry (David P) Individual Investor 53.1606 16868581 6404566 2023-04-12 LOW
    Georgianna Maule-Ffinch 2015 Trust Individual Investor 11.4598 3636364 3636364 2023-04-10
    Appelbaum (Kevin J) Individual Investor 7.5847 2406719 -6250 2023-04-10 LOW
    Mountain Crest Capital LLC Corporation 4.375 1388250 0 2023-04-10 LOW
    Farallon Capital Management, L.L.C. Hedge Fund 2.203 699042 -114514 2023-03-31 MED
    Armanino (Andrew J) Individual Investor 1.4739 467692 303030 2023-04-10 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.3818 438479 3700 2023-03-31 LOW
    Parker (Geoffrey M) Individual Investor 1.2491 396363 303030 2023-04-10 LOW
    Maule-Ffinch (Georgianna) Individual Investor 0.9238 293150 0 2023-04-10 LOW
    Karbe (Frank L) Individual Investor 0.9216 292424 242424 2023-04-10 MED
    Berman Mark A Individual Investor 0.7309 231939 0 2023-04-10 LOW
    Carmona (Richard H. M.D.) Individual Investor 0.4841 153619 0 2023-04-10 LOW
    Wynholds (Kristin) Individual Investor 0.3114 98819 0 2023-04-10 LOW
    Heinen (Mark) Individual Investor 0.2773 88004 1 2023-04-10 MED
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.2523 80054 798 2023-03-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.18 57109 0 2023-03-31 LOW
    Susquehanna International Group, LLP Investment Advisor 0.1497 47516 -6473 2023-03-31 MED
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1424 45200 0 2023-03-31 LOW
    Zamirowski (Justin) Individual Investor 0.1163 36913 36913 2022-05-27
    Millennium Management LLC Hedge Fund 0.0837 26556 14932 2023-03-31 HIGH

    Why choose Capital.com? Our numbers speak for themselves.

    Capital.com Group

    530K+

    Traders

    87K+

    Active clients monthly

    $46M+

    Monthly investing volume

    $31M+

    Withdrawn each month

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Profit/Loss

    Better Therapeutics, Inc. Company profile

    About Better Therapeutics Inc

    Better Therapeutics, Inc, formerly Mountain Crest Acquisition Corp II, is engaged in offering prescription digital therapeutics platform for treating cardiometabolic diseases. The Company creates treatments to reverse the progression of disease, improve quality of life, and inform clinical decisions. It builds prescription digital therapeutics that deliver a new kind of behavioral therapy and creating feedback mechanisms using remotely-monitored and patient-generated data. Its clinical development pipeline includes BT-001, BT-002, BT-003, BT-004 and BT-005. It is evaluating BT-001 in a pivotal study as a prescribed treatment used under physician supervision for people with uncontrolled type 2 diabetes. The Company develops Nutritional Cognitive Behavioral Therapy (Nutritional CBT), which is a novel form of behavioral therapy under development for the treatment of patients with type 2 diabetes and other cardiometabolic diseases.

    Financial summary

    BRIEF: For the nine months ended 30 September 2021, Better Therapeutics Inc revenues was not reported. Net loss totaled to $550K.

    Industry: Biotechnology & Medical Research (NEC)

    548 Market St. #49404
    SAN FRANCISCO
    CALIFORNIA 94101
    US

    Income Statement

    • Annual
    • Quarterly

    News

    Benjamin Franklin’s face on a $100 bill

    USD forecast: DXY slides in risk-off market sentiment

    The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.

    16:10, 24 May 2023
    Oil wells pictured in an oil field, silhouetted against clouds

    Oil price forecast: Will WTI and Brent regain momentum in 2023?

    Discover the drivers behind Brent and WTI volatility and get insights from analyst predictions.

    11:38, 22 May 2023
    businessman using a mobile phone to check stock market data

    Weekly Roundup: Tech stocks lead the way

    US stocks push higher as risk appetite surges despite the uncertainty

    13:39, 19 May 2023
    Japanese yen currency

    USD/JPY continues to build higher towards 138

    USD/JPY advances towards the top of its ascending triangle as the US dollar moves higher

    11:50, 17 May 2023
    Gold bars on a black background with a diagram

    Gold price predictions for next 5 years: Will gold continue rising?

    The yellow metal reached near record-highs, yet will it maintain the momentum and for how long?

    07:50, 17 May 2023
    Close-up of a $20 banknote and gold bullion

    Gold price forecast: Will gold surpass record highs?

    The US debt ceiling concerns and the banking crisis have been favourable for gold, yet is there more upside potential?

    12:52, 16 May 2023

    Top AI stocks: What companies are leading the AI revolution?

    Unravel key AI market leaders and their latest products, key AI industry trends and forecasts.

    14:55, 15 May 2023

    People also watch

    Oil - Crude

    72.94 Price
    +1.570% 1D Chg, %
    Long position overnight fee -0.0154%
    Short position overnight fee -0.0065%
    Overnight fee time 21:00 (UTC)
    Spread 0.04

    Gold

    1,946.90 Price
    +0.290% 1D Chg, %
    Long position overnight fee -0.0185%
    Short position overnight fee 0.0103%
    Overnight fee time 21:00 (UTC)
    Spread 0.60

    XRP/USD

    0.47 Price
    +1.040% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.00319

    BTC/USD

    27,231.90 Price
    +1.710% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 60.00

    Still looking for a broker you can trust?

    Join the 530.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading